Immune Pharmaceuticals Announces New Data with Topical Cyclosporine Nano-Capsules in Dermatology - Stock Watch Index

Immune Pharmaceuticals Announces New Data with Topical Cyclosporine Nano-Capsules in Dermatology

February 1, 2016

Immune Acquires Worldwide Rights and Accelerates Development for the Treatment of Psoriasis and Atopic Dermatitis NEW YORK, Jan. 4, 2016 /PRNewswire/ — Immune Pharmaceuticals Inc. (NASDAQ: IMNP), “Immune”, a clinical-stage biopharmaceutical company, announced today that following the review of new efficacy data, it has entered into an exclusive worldwide licensing and development agreement with BioNanoSim Ltd…

Search

RECENT PRESS RELEASES

Avicanna Partners with Vectura Fertin Pharma to Advance Medical Cannabis Research in Canada

SWI Editorial Staff2025-01-16T05:08:15-08:00January 16, 2025|

Trulieve Cannabis price target lowered to C$19 from C$23 at Alliance Global Partners

SWI Editorial Staff2025-01-16T05:08:15-08:00January 16, 2025|

Los Angeles wildfires rage as strong winds put millions at risk

SWI Editorial Staff2025-01-16T05:08:05-08:00January 16, 2025|

State Farm to offer renewals to policyholders affected by L.A. County fires

SWI Editorial Staff2025-01-16T05:08:03-08:00January 16, 2025|

Brehm: Climate change didn’t cause the Los Angeles wildfires. Government incompetence did.

SWI Editorial Staff2025-01-16T05:07:59-08:00January 16, 2025|

A long road to rebuilding — and fights over government funding — await L.A. fire victims

SWI Editorial Staff2025-01-16T05:07:57-08:00January 16, 2025|

Related Post